Novartis Pharmaceuticals Corporation

Announcement

Diversity Inc recognizes Novartis as one of the top 50 companies for Diversity

For the fourth year in a row, Novartis Pharmaceuticals Corporation has been recognized by Diversity Inc, a leading publication on diversity and business, as one of the Top 50 Companies for Diversity in the US.

Latest News

Focalin� XR (dexmethylphenidate hydrochloride) extended-release capsules

November 02, 2009

Full Prescribing Information

Novartis Pharmaceuticals Corporation Prevails In Medicaid Pricing Case Before Alabama Supreme Court

October 19, 2009

Novartis receives Complete Response letter from FDA for QAB149, an investigational bronchodilator for COPD

October 19, 2009

Novartis enters into agreement for exclusive US and Canadian rights to Fanapt^TM, an FDA-approved oral therapy for schizophrenia

October 12, 2009

Valturna� (aliskiren and valsartan, USP) tablets

September 17, 2009

Full Prescribing Information

Extavia� (interferon beta-1b) injection

August 17, 2009

Full Prescribing Information

View All News

Our Products

For Healthcare Professionals

Corporate Citizenship is an integral part of how we operate and a key to our success. Learn more about how wew help.

HELPING THOSE IN NEED

Helping Those in Need

At Novartis Pharmaceuticals Corporation, we believe that all Americans deserve access to quality health care. Find out about a resource that allows you to access programs that may help you pay for your Novartis medicines.

Find out more at Patient Assistance Now.com

Novartis Pharmaceuticals Corporation supports a range of grants to support education, advocacy and outreach efforts. Call 1-888-NOW-Nova.

Learn more